AssuranceSelect 7 Plus with MVA review

Yes, for buyers in the right states with the right time horizon. This is a structurally sound accumulation FIA from a carrier that almost never gets questioned on financial strength. The broad index menu and optional income rider give it more flexibility than a bare-bones FIA. The honest caveats are the MVA risk on early withdrawals and the currently limited state availability. If you are in one of the four approved states and can commit to the 7-year timeline, this is a strong option.

The main draw is carrier quality. MassMutual Ascend sits behind one of the highest possible A.M. Best ratings (A++), and that matters to buyers who prioritize the creditworthiness of the insurance company itself. Beyond that, the crediting menu is genuinely broad — nine strategies across six indices including a 7-year cap-lock option on the S&P 500 and niche plays like the iShares U.S. Real Estate ETF and SPDR Gold Shares. Buyers also get the option to attach the Income Ascender rider later if income planning becomes a priority, which builds in optionality without forcing them to pay for it from day one.

I think AssuranceSelect 7 Plus with MVA is best for someone in their mid-50s to early 70s who wants principal protection with upside potential, values the backing of a mutual life company, and can realistically leave the money untouched for seven years. It fits both qualified and non-qualified accounts. It is not the right product for someone who might need more than 10% of the value before year seven, who is shopping based purely on the highest available cap rate, or who is located outside the four currently approved states.

You are buying a principal-protected accumulation vehicle with index-linked growth potential — not a market investment. Every indexed strategy in this contract credits interest based on a formula (cap, participation rate, or point-to-point measurement) rather than your direct ownership of any index. The floor is zero on all strategies, which means your account value will not go backward from index losses, but it also means you will not capture full market upside. The MVA is worth understanding carefully: it is a mechanism that adjusts your surrender value up or down based on changes in a reference interest rate, which means the effective cost of leaving early is tied to the interest-rate environment, not just the scheduled surrender charge.

AssuranceSelect 7 Plus with MVA gives you nine crediting strategies to choose from. On the S&P 500, you can use a standard 1-year point-to-point cap, a participation-rate strategy tied to the S&P 500 Average Daily Risk Control 10% index, or a 7-year cap-lock option where the cap rate is set at issue and locked for the full 7-year term. The 7-year cap-lock is one of the more distinctive features here — it removes the annual uncertainty of cap-rate resets for buyers who want to set their crediting terms and leave them. Beyond the S&P, you can allocate to the S&P U.S. Retiree Spending Index via participation rate, or to cap-based strategies on the iShares U.S. Real Estate ETF, SPDR Gold Shares, and the First Trust Barclays Edge Index (available in both 1-year and 7-year lock formats). A declared-rate fixed account is also available. The guaranteed minimum on all indexed strategies is 0% — your principal is protected against negative index years.

The optional Income Ascender rider is the most meaningful secondary feature. It is available for an additional fee (1.10% current annual charge, with a range up to 2.50%) and provides a benefit base that grows at 9.00% simple annual interest during the accumulation phase. That roll-up rate is competitive for this type of rider, and having it available as an option — rather than baked in with a mandatory fee — means accumulation-focused buyers do not pay for it unless and until they decide they want it. The Extended Care Waiver and Terminal Illness Waiver Riders are included at no charge and can waive surrender charges in qualifying health events, which adds meaningful protection without adding to the fee load.

The free-withdrawal provision is workable. In year one, you can take out up to 10% of premiums paid without penalty. From year two forward, you get 10% of the prior anniversary account value plus any purchase payments made since that anniversary. That is a slightly more generous calculation than contracts that limit free withdrawals to a flat 10% of the original premium throughout.

The surrender charge schedule runs eight years, declining from 8% in years one and two through 3% in year seven, then zero. The MVA — Market Value Adjustment — is applied on top of surrender charges during the surrender period. When interest rates rise relative to the rate in effect when you bought the contract, the MVA works against you; when rates fall, it can reduce your effective exit cost. That two-sided exposure is worth understanding before you buy, because it makes the real cost of an early exit harder to predict than a contract without an MVA.

The base contract has no stated annual product fee, which keeps the accumulation math cleaner. If you add the Income Ascender rider, the current fee is 1.10% per year, with a contractual maximum of 2.50%. The Inheritance Enhancer II death-benefit rider carries a current fee of 1.15% with a maximum of 2.50%. Both rider fees are applied annually to the benefit base, not the account value, which affects how the drag actually works over time — ask for the illustration to see the numbers clearly.

The structural tradeoff that accumulation buyers pay regardless of riders is cap-and-participation-rate compression. You do not capture the full index return on the 1-year strategies; you capture it up to a cap or at a stated participation percentage. The 7-year cap-lock strategies give you certainty on the rate but tie you to whatever cap or participation rate was offered at issue. The declared rate strategy is simple but is ultimately a guaranteed-but-modest growth path.

Legal Entity: MassMutual Ascend Life Insurance Company

Parent: Massachusetts Mutual Life Insurance Company

A.M. Best Rating: A++

MassMutual Ascend is a subsidiary of Massachusetts Mutual Life Insurance Company, a mutual life insurer with one of the strongest financial strength profiles in the industry. The A++ A.M. Best rating is the highest rating that agency assigns and is shared by very few annuity carriers. For buyers who weight carrier stability heavily — particularly those with large premium amounts or long time horizons — that backing is meaningful.